S&P 500   3,370.39 (-0.09%)
DOW   27,822.88 (-0.26%)
AAPL   456.00 (-0.88%)
MSFT   208.47 (-0.11%)
FB   261.55 (+0.10%)
GOOGL   1,517.59 (+0.06%)
AMZN   3,158.74 (-0.07%)
NVDA   464.48 (+1.48%)
CGC   17.17 (-0.87%)
BABA   256.20 (+0.98%)
TSLA   1,661.13 (+2.48%)
GE   6.58 (-0.30%)
MU   45.58 (-1.21%)
AMD   82.68 (+1.03%)
T   29.91 (-0.07%)
F   7.01 (-0.28%)
GILD   68.27 (+0.13%)
NFLX   485.78 (+0.92%)
DIS   130.00 (-0.73%)
BAC   26.18 (-0.65%)
BA   173.60 (-0.65%)
S&P 500   3,370.39 (-0.09%)
DOW   27,822.88 (-0.26%)
AAPL   456.00 (-0.88%)
MSFT   208.47 (-0.11%)
FB   261.55 (+0.10%)
GOOGL   1,517.59 (+0.06%)
AMZN   3,158.74 (-0.07%)
NVDA   464.48 (+1.48%)
CGC   17.17 (-0.87%)
BABA   256.20 (+0.98%)
TSLA   1,661.13 (+2.48%)
GE   6.58 (-0.30%)
MU   45.58 (-1.21%)
AMD   82.68 (+1.03%)
T   29.91 (-0.07%)
F   7.01 (-0.28%)
GILD   68.27 (+0.13%)
NFLX   485.78 (+0.92%)
DIS   130.00 (-0.73%)
BAC   26.18 (-0.65%)
BA   173.60 (-0.65%)
S&P 500   3,370.39 (-0.09%)
DOW   27,822.88 (-0.26%)
AAPL   456.00 (-0.88%)
MSFT   208.47 (-0.11%)
FB   261.55 (+0.10%)
GOOGL   1,517.59 (+0.06%)
AMZN   3,158.74 (-0.07%)
NVDA   464.48 (+1.48%)
CGC   17.17 (-0.87%)
BABA   256.20 (+0.98%)
TSLA   1,661.13 (+2.48%)
GE   6.58 (-0.30%)
MU   45.58 (-1.21%)
AMD   82.68 (+1.03%)
T   29.91 (-0.07%)
F   7.01 (-0.28%)
GILD   68.27 (+0.13%)
NFLX   485.78 (+0.92%)
DIS   130.00 (-0.73%)
BAC   26.18 (-0.65%)
BA   173.60 (-0.65%)
S&P 500   3,370.39 (-0.09%)
DOW   27,822.88 (-0.26%)
AAPL   456.00 (-0.88%)
MSFT   208.47 (-0.11%)
FB   261.55 (+0.10%)
GOOGL   1,517.59 (+0.06%)
AMZN   3,158.74 (-0.07%)
NVDA   464.48 (+1.48%)
CGC   17.17 (-0.87%)
BABA   256.20 (+0.98%)
TSLA   1,661.13 (+2.48%)
GE   6.58 (-0.30%)
MU   45.58 (-1.21%)
AMD   82.68 (+1.03%)
T   29.91 (-0.07%)
F   7.01 (-0.28%)
GILD   68.27 (+0.13%)
NFLX   485.78 (+0.92%)
DIS   130.00 (-0.73%)
BAC   26.18 (-0.65%)
BA   173.60 (-0.65%)
Log in

NASDAQ:HTGMHTG Molecular Diagnostics SEC Filings & 10K Form

$0.48
-0.05 (-8.65 %)
(As of 08/14/2020 10:13 AM ET)
Add
Compare
Today's Range
$0.46
Now: $0.48▼
$0.52
50-Day Range
$0.54
MA: $0.65▼
$0.79
52-Week Range
$0.27
Now: $0.48▼
$1.10
Volume80,693 shs
Average Volume3.11 million shs
Market Capitalization$31.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.73

SEC Filings

HTG Molecular Diagnostics (NASDAQ:HTGM) SEC Filings

DateFilerForm TypeView
08/11/2020
3:10 PM		HTG Molecular Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2020
3:06 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2020
11:52 AM		HTG Molecular Diagnostics (Filer)
Form CT ORDER
07/07/2020
3:15 PM		HTG Molecular Diagnostics (Filer)
Form DEFA14A
07/07/2020
3:05 PM		HTG Molecular Diagnostics (Filer)
Form DEF 14A
06/26/2020
4:22 PM		HTG Molecular Diagnostics (Filer)
Form PRE 14A
06/25/2020
3:45 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
5:21 PM		HTG Molecular Diagnostics (Issuer)
Lawson Byron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:19 PM		Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:17 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:15 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:13 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
8:11 PM		Blue Water Life Science Master Fund, Ltd. (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G/A
05/13/2020
3:10 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2020
5:05 AM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2020
4:28 PM		HTG Molecular Diagnostics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2020
11:35 AM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
8:46 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
8:43 PM		HTG Molecular Diagnostics (Filer)
Form 424B5
02/26/2020
7:22 AM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
11:23 AM		HTG Molecular Diagnostics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G
02/04/2020
9:35 AM		Cowen Prime Services LLC (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G
01/31/2020
2:29 PM		HTG Molecular Diagnostics (Subject)
Samjo Capital LLC (Filed by)
Form SC 13G
01/27/2020
4:26 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
3:40 PM		Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:38 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:37 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
7:05 AM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2020
3:53 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:52 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:50 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:42 PM		Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:36 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:32 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
11:15 PM		HTG Molecular Diagnostics (Filer)
Form EFFECT
11/18/2019
3:15 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
3:07 PM		HTG Molecular Diagnostics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/10/2019
10:35 AM		FMR LLC (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G/A
10/07/2019
5:03 AM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
3:29 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:27 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
10:05 AM		HTG Molecular Diagnostics (Subject)
Serrado Capital LLC (Filed by)
Form SC 13G
09/30/2019
7:38 AM		Blue Water Life Science Master Fund, Ltd. (Filed by)
HTG Molecular Diagnostics (Subject)
Form SC 13G
09/27/2019
5:52 PM		HTG Molecular Diagnostics (Issuer)
LYTTON LAURENCE W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/23/2019
4:19 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
4:16 PM		HTG Molecular Diagnostics (Filer)
Form 424B5
09/19/2019
3:05 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
3:02 PM		HTG Molecular Diagnostics (Filer)
Form 424B5
09/16/2019
3:45 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
3:42 PM		Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
3:20 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:28 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
4:24 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
4:20 PM		Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:34 PM		GRIFFIN MICHELLE RENEE (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:32 PM		HTG Molecular Diagnostics (Issuer)
McCracken Lee R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:30 PM		HARDISON DON M (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:27 PM		George Harry A. (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:24 PM		HANHAM ANN (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:21 PM		HTG Molecular Diagnostics (Issuer)
LAFRANCE JAMES T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:22 PM		HTG Molecular Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:10 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
3:20 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:19 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
12:39 PM		HTG Molecular Diagnostics (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G
06/14/2019
4:05 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
8:34 AM		Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
8:33 AM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
8:31 AM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
3:54 PM		Godlewski Laura Lee (Reporting)
HTG Molecular Diagnostics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2019
3:50 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
4:21 PM		HTG Molecular Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2019
3:05 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
3:44 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
7:02 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
6:57 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
6:55 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
9:43 AM		HTG Molecular Diagnostics (Filer)
Form CT ORDER
03/13/2019
3:07 PM		HTG Molecular Diagnostics (Filer)
Form 424B5
03/13/2019
3:01 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
3:10 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2019
3:10 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
1:09 PM		HTG Molecular Diagnostics (Subject)
Merck Capital Ventures LLC (Filed by)
Form SC 13G/A
02/14/2019
12:51 PM		HTG Molecular Diagnostics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
02/13/2019
3:16 PM		HTG Molecular Diagnostics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/11/2019
11:15 PM		HTG Molecular Diagnostics (Filer)
Form EFFECT
01/30/2019
3:00 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2019
3:03 PM		HTG Molecular Diagnostics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/14/2019
3:48 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
7:15 AM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2019
8:41 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
8:38 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
8:37 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
3:31 PM		HTG Molecular Diagnostics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/17/2018
3:35 PM		HTG Molecular Diagnostics (Issuer)
McMeans Shaun D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
3:34 PM		HTG Molecular Diagnostics (Issuer)
Lubniewski John L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
3:31 PM		HTG Molecular Diagnostics (Issuer)
JOHNSON TIM B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
9:14 AM		HTG Molecular Diagnostics (Filer)
Form CT ORDER
11/08/2018
3:22 PM		HTG Molecular Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:10 PM		HTG Molecular Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 8/14/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.